Candriam SCA’s Sarepta Therapeutics SRPT Stock Holding History

Candriam SCA’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-56,282	Closed	-$3.59M	–	720
2025 Q1	$3.59M	Sell	56,282 -357	-0.6%	-$22.8K	0.02%	396
2024 Q4	$6.89M	Sell	56,639 -2,869	-5%	-$349K	0.04%	312
2024 Q3	$7.43M	Sell	59,508 -69,492	-54%	-$8.68M	0.04%	302
2024 Q2	$20.4M	Sell	129,000 -22,000	-15%	-$3.48M	0.12%	165
2024 Q1	$19.5M	Sell	151,000 -31,445	-17%	-$4.07M	0.13%	169
2023 Q4	$17.6M	Buy	182,445 +46,736	+34%	+$4.51M	0.12%	174
2023 Q3	$16.5M	Buy	135,709 +35,709	+36%	+$4.33M	0.12%	168
2023 Q2	$11.5M	Sell	100,000 -22,194	-18%	-$2.54M	0.08%	230
2023 Q1	$15.5M	Buy	122,194 +27,050	+28%	+$3.43M	0.11%	199
2022 Q4	$12.3M	Buy	+95,144	New	+$12.3M	0.08%	231
2021 Q2	–	Sell	-164,008	Closed	-$26.9M	–	938
2021 Q1	$26.9M	Hold	164,008	–	–	0.22%	119
2020 Q4	$28M	Sell	164,008 -10,821	-6%	-$1.84M	0.22%	119
2020 Q3	$24.6M	Hold	174,829	–	–	0.23%	104
2020 Q2	$28M	Buy	174,829 +9,729	+6%	+$1.56M	0.3%	86
2020 Q1	$20.8M	Hold	165,100	–	–	0.23%	92
2019 Q4	$21.3M	Sell	165,100 -27,500	-14%	-$3.55M	0.23%	92
2019 Q3	$14.5M	Hold	192,600	–	–	0.19%	124
2019 Q2	$29.1M	Hold	192,600	–	–	0.36%	54
2019 Q1	$23M	Buy	192,600 +66,500	+53%	+$7.93M	0.29%	73
2018 Q4	$13.8M	Buy	126,100 +3,000	+2%	+$327K	0.21%	112
2018 Q3	$19.9M	Buy	123,100 +64,100	+109%	+$10.4M	0.26%	88
2018 Q2	$7.8M	Buy	59,000 +11,000	+23%	+$1.45M	0.12%	209
2018 Q1	$3.56M	Buy	48,000 +6,000	+14%	+$445K	0.06%	349
2017 Q4	$2.34M	Buy	+42,000	New	+$2.34M	0.04%	426
2016 Q2	–	Sell	-43,000	Closed	-$835K	–	675
2016 Q1	$835K	Buy	43,000 +23,000	+115%	+$447K	0.02%	456
2015 Q4	$772K	Sell	20,000 -21,800	-52%	-$841K	0.02%	417
2015 Q3	$1.34M	Buy	41,800 +1,800	+5%	+$57.8K	0.03%	396
2015 Q2	$1.22M	Sell	40,000 -30,000	-43%	-$913K	0.03%	421
2015 Q1	$930K	Buy	70,000 +10,000	+17%	+$133K	0.02%	458
2014 Q4	$868K	Buy	+60,000	New	+$868K	0.02%	455